Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
New TAVR valve, the first of its kind, linked to strong 1-year performance | AI & electrophysiology
Thursday, May 25, 2023
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

New biomimetic TAVR valve, the first of its kind, linked to strong performance after 1 year

The DurAVR transcatheter heart valve, developed by Minnesota-based Anteris Technologies, was designed to move and perform like a healthy, pre-disease native aortic valve.

READ MORE >
The DurAVR transcatheter heart valve (THV), developed by Minnesota-based Anteris Technologies
Share on Twitter Share on Facebook Share on Linkedin

New biomimetic TAVR valve, the first of its kind, linked to strong performance after 1 year

Share on Twitter Share on Facebook Share on Linkedin
The DurAVR transcatheter heart valve (THV), developed by Minnesota-based Anteris Technologies
The DurAVR transcatheter heart valve, developed by Minnesota-based Anteris Technologies, was designed to move and perform like a healthy, pre-disease native aortic valve.
READ MORE >

AI gaining popularity in electrophysiology

There are now numerous AI algorithms for electrophysiology. Jagmeet Singh, MD, examined how this advanced technology is being applied.

READ MORE >
The proliferation of artificial intelligence (AI) in healthcare includes numerous algorithms for electrophysiology (EP). Jagmeet Singh, MD, Professor of Medicine, Harvard Medical School, and founding director of the Resynchronization and Advanced Cardiac Therapeutics Program and Mass General Hospital, spoke with Cardiovascular Business at Heart Rhythm 2023 to explain how AI is being used in EP. #HRS2023 #HRS #AI
Share on Twitter Share on Facebook Share on Linkedin

AI gaining popularity in electrophysiology

Share on Twitter Share on Facebook Share on Linkedin
The proliferation of artificial intelligence (AI) in healthcare includes numerous algorithms for electrophysiology (EP). Jagmeet Singh, MD, Professor of Medicine, Harvard Medical School, and founding director of the Resynchronization and Advanced Cardiac Therapeutics Program and Mass General Hospital, spoke with Cardiovascular Business at Heart Rhythm 2023 to explain how AI is being used in EP. #HRS2023 #HRS #AI
There are now numerous AI algorithms for electrophysiology. Jagmeet Singh, MD, examined how this advanced technology is being applied.
READ MORE >

AI correctly IDs ventricular arrhythmias in 88% of patients with sustained VT

New research suggests AI could offer physicians a new, state-of-the-art approach to sudden cardiac arrest risk management.

READ MORE >
Artificial intelligence (AI) analysis from a remote ECG monitor showing the AI generated report on the Philips Cardiologs system, during a demonstration of the technology at Heart Rhythm 2023. Photo by Dave Fornell
Share on Twitter Share on Facebook Share on Linkedin

AI correctly IDs ventricular arrhythmias in 88% of patients with sustained VT

Share on Twitter Share on Facebook Share on Linkedin
Artificial intelligence (AI) analysis from a remote ECG monitor showing the AI generated report on the Philips Cardiologs system, during a demonstration of the technology at Heart Rhythm 2023. Photo by Dave Fornell
New research suggests AI could offer physicians a new, state-of-the-art approach to sudden cardiac arrest risk management.
READ MORE >

Featured Articles

Early success of dual-chamber leadless pacemaker suggests big changes could be on the horizon

Daniel Cantillon, MD, explained why the positive performance of Abbott's Aveir dual-chamber leadless pacemaker could lead to considerable improvements in patient care. 

READ MORE >
Daniel Cantillon, MD, said the first leadless, dual-chamber pacing system performed very well in the Aveir dual-chamber i2i trial. #HRS #HRS23
Share on Twitter Share on Facebook Share on Linkedin

Early success of dual-chamber leadless pacemaker suggests big changes could be on the horizon

Share on Twitter Share on Facebook Share on Linkedin
Daniel Cantillon, MD, said the first leadless, dual-chamber pacing system performed very well in the Aveir dual-chamber i2i trial. #HRS #HRS23
Daniel Cantillon, MD, explained why the positive performance of Abbott's Aveir dual-chamber leadless pacemaker could lead to considerable improvements in patient care. 
READ MORE >

Cardiologist accused of date rape by multiple women agrees not to practice medicine during investigation

The agreement, not technically an admission of guilt, is expected to stay in effect until the investigation is resolved. 

READ MORE >
A gavel and a stethoscope
Share on Twitter Share on Facebook Share on Linkedin

Cardiologist accused of date rape by multiple women agrees not to practice medicine during investigation

Share on Twitter Share on Facebook Share on Linkedin
A gavel and a stethoscope
The agreement, not technically an admission of guilt, is expected to stay in effect until the investigation is resolved. 
READ MORE >

Imaging results more helpful than genetics when predicting heart disease, new head-to-head study confirms

The new analysis, published in JAMA, suggests that CT results can help identify medium- and high-risk patients who may need to be considered for statin therapy or other preventive treatments.

READ MORE >
A CTA scan being performed at Beaumont Hospital in Michigan by cardiac CT expert Kavitha M Chinnaiyan, MD. CCTA has largely been used at academic medical centers for the past decade, but it is now expanding in 2022 to community hospitals and clinics thanks to a Class 1A recommendation in the 2021 chest pain guidelines. #CCTA #CTA #Beaumont
Share on Twitter Share on Facebook Share on Linkedin

Imaging results more helpful than genetics when predicting heart disease, new head-to-head study confirms

Share on Twitter Share on Facebook Share on Linkedin
A CTA scan being performed at Beaumont Hospital in Michigan by cardiac CT expert Kavitha M Chinnaiyan, MD. CCTA has largely been used at academic medical centers for the past decade, but it is now expanding in 2022 to community hospitals and clinics thanks to a Class 1A recommendation in the 2021 chest pain guidelines. #CCTA #CTA #Beaumont
The new analysis, published in JAMA, suggests that CT results can help identify medium- and high-risk patients who may need to be considered for statin therapy or other preventive treatments.
READ MORE >

In Case You Missed It

Cardiology has embraced AI more than most other specialties

Cardiology is linked to the second largest group of FDA-cleared clinical AI algorithms, and the number is still growing. 

READ MORE >
An example of HeartFlow's new RoadMap Stenosis software that uses artificial intelligence (AI) to show areas of interest for possible stenting based on a patient's CT scan and FFR-CT. This software is still undergoing beta testing at several hospitals and will likely be rolled out commercially later in 2023.
Share on Twitter Share on Facebook Share on Linkedin

Cardiology has embraced AI more than most other specialties

Share on Twitter Share on Facebook Share on Linkedin
An example of HeartFlow's new RoadMap Stenosis software that uses artificial intelligence (AI) to show areas of interest for possible stenting based on a patient's CT scan and FFR-CT. This software is still undergoing beta testing at several hospitals and will likely be rolled out commercially later in 2023.
Cardiology is linked to the second largest group of FDA-cleared clinical AI algorithms, and the number is still growing. 
READ MORE >

TVT 2023: Cardiovascular Research Foundation announces late-breaking clinical trials

In addition to these 15 late-breaking clinical studies, TVT 2023 will feature live cases, hands-on training, poster presentations and much more.

READ MORE >
A transcatheter aortic valve replacement (TAVR) procedure being performed at Intermountain Healthcare. Image from Intermountain Healthcare. Sex differences in TAVR one-year mortality.
Share on Twitter Share on Facebook Share on Linkedin

TVT 2023: Cardiovascular Research Foundation announces late-breaking clinical trials

Share on Twitter Share on Facebook Share on Linkedin
A transcatheter aortic valve replacement (TAVR) procedure being performed at Intermountain Healthcare. Image from Intermountain Healthcare. Sex differences in TAVR one-year mortality.
In addition to these 15 late-breaking clinical studies, TVT 2023 will feature live cases, hands-on training, poster presentations and much more.
READ MORE >

In Other News

Federal Trade Commission issues warning to health companies about the misuse of consumer data

The new policy statement warns that any inaccurate or misleading claims to consumers about how their data is collected and used will be considered a violation of the FTC Act.

READ MORE >
personal_data.jpg
Share on Twitter Share on Facebook Share on Linkedin

Federal Trade Commission issues warning to health companies about the misuse of consumer data

Share on Twitter Share on Facebook Share on Linkedin
personal_data.jpg
The new policy statement warns that any inaccurate or misleading claims to consumers about how their data is collected and used will be considered a violation of the FTC Act.
READ MORE >

Adopting paid family and medical leave in radiology: 7 considerations

“Paid FML is increasingly being recognized as an important issue in medicine," radiologists wrote recently in AJR. 

READ MORE >
ACR: FDA evidence backing thyroid monitoring in peds after ICM use is 'weak' #contrast #FDA #contrastshortage
Share on Twitter Share on Facebook Share on Linkedin

Adopting paid family and medical leave in radiology: 7 considerations

Share on Twitter Share on Facebook Share on Linkedin
ACR: FDA evidence backing thyroid monitoring in peds after ICM use is 'weak' #contrast #FDA #contrastshortage
“Paid FML is increasingly being recognized as an important issue in medicine," radiologists wrote recently in AJR. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Cardiologists added to payment model by mistake | Sex-specific outcomes after TAVR & SAVR | FDA clears new AI software
Private equity unlikely to dominate cardiology | Cardiology opposes Medicare AI prior authorization | New AATS leaders
The real impact of RVU cuts in electrophysiology | TAVR changes on the way | Cardiology groups celebrate bill | BP drug recalled
Blood may leak out of Impella introducers | Leadless conduction and Bachmann's pacing | US study for microvascular disease
Top 10 most popular cardiology video interviews this past month
Week in Review: CCTA on ACC expo floor gives cardiologist wake-up call | Reaction to CMS TAVR changes | Recalls and new AI
CCTA scan provides a wake-up call | Resistance training & heart attack risk in women | New ultrasound tech | AFib & grout

Pagination

    • First page « First
    • Previous page ‹‹
    • Page 1
    • Current page 2
    • Page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup